Anti-p40 antibody [EPR13781]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal p40 antibody. Suitable for WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
RAB9P40, RABEPK, Rab9 effector protein with kelch motifs, 40 kDa Rab9 effector protein, p40
- WB
Lab
Western blot - Anti-p40 antibody [EPR13781] (AB184173)
Western blot : Anti-p40 antibody [EPR13781] ab184173 staining at 1/2000 dilution, shown in green; Mouse anti alpha Tubulin ab7291 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 40 kDa in Wild-type A549 cell lysates with no signal observed at this size in RABEPK knockout A549 cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-p40 antibody [EPR13781] (ab184173) at 1/2000 dilution
Lane 1:
Wild-type A549 at 20 µg
Lane 2:
RABEPK knockout A549 at 20 µg
Lane 3:
HeLa at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 41 kDa
Observed band size: 40 kDa,51 kDa
false
- WB
Supplier Data
Western blot - Anti-p40 antibody [EPR13781] (AB184173)
5% NFDM/TBST blocking/dilution buffer
All lanes:
Western blot - Anti-p40 antibody [EPR13781] (ab184173) at 1/2000 dilution
Lane 1:
HepG2 cell lysate at 20 µg
Lane 2:
HeLa cell lysate at 20 µg
Lane 3:
U87-MG cell lysate at 20 µg
Lane 4:
Jurkat cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 41 kDa
false
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The p40 subunit forms part of the heterodimer complexes IL-12 and IL-23 which have different roles in the immune response. IL-12 which includes the p35 subunit alongside p40 is key for the differentiation of naive T cells into Th1 cells. This action leads to enhancement of the cellular immune response. In contrast the combination of p40 with p19 forms IL-23 which supports the survival and proliferation of Th17 cells playing a unique role in maintaining tissue integrity and combating extracellular pathogens.
Pathways
The p40 protein interacts significantly in the IL-12 and IL-23 signaling pathways which are essential for immune regulation and response. In these pathways IL-12 and IL-23 bind to their respective receptors leading to downstream effects that encourage the activation and differentiation of T cells. The signaling pathways involve other proteins such as STAT4 important for IL-12-dependent responses and STAT3 which is important for IL-23-mediated pathways. These interactions show how p40 contributes to complex and critical immune network regulation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
American journal of cancer research 12:5286-5299 PubMed36504904
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com